Do Patients with Apparently Resectable Pancreatic Adenocarcinoma Receive Guideline-Directed Care?

Authors

Joon K. Shim, Wright State UniversityFollow
May Piperdi
Theodore P. McDade
Giles L. Whalen
Mary E. Sullivan
Bilal Piperdi
Jennifer F. Tseng

Document Type

Abstract

Publication Date

5-20-2008

Abstract

Meaningful survival for patients with pancreatic cancer requires surgical resection; adjuvant therapy has been demonstrated to improve survival.

Comments

Presented at the American Society of Clinical Oncology's 44th Annual Meeting, Chicago, IL, May 30-June 3, 2008.

Repository Citation

Shim, J. K., Piperdi, M., McDade, T. P., Whalen, G. L., Sullivan, M. E., Piperdi, B., & Tseng, J. F. (2008). Do Patients with Apparently Resectable Pancreatic Adenocarcinoma Receive Guideline-Directed Care?. Journal of Clinical Oncology, 26 (15S), 15579.
https://corescholar.libraries.wright.edu/surg/698